Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging

Abstract Insights regarding the biodistribution and homing of mesenchymal stromal cells (MSCs), as well as their interaction with alloreactive T-cells are critical for understanding how MSCs can regulate graft-versus-host disease (GVHD) following allogeneic (allo) bone marrow transplantation (BMT)....

Full description

Bibliographic Details
Main Authors: Patiwet Wuttisarnwattana, Saada Eid, David L. Wilson, Kenneth R. Cooke
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-28478-3
_version_ 1797864741975097344
author Patiwet Wuttisarnwattana
Saada Eid
David L. Wilson
Kenneth R. Cooke
author_facet Patiwet Wuttisarnwattana
Saada Eid
David L. Wilson
Kenneth R. Cooke
author_sort Patiwet Wuttisarnwattana
collection DOAJ
description Abstract Insights regarding the biodistribution and homing of mesenchymal stromal cells (MSCs), as well as their interaction with alloreactive T-cells are critical for understanding how MSCs can regulate graft-versus-host disease (GVHD) following allogeneic (allo) bone marrow transplantation (BMT). We developed novel assays based on 3D, microscopic, cryo-imaging of whole-mouse-sized volumes to assess the therapeutic potential of human MSCs using an established mouse GVHD model. Following infusion, we quantitatively tracked fluorescently labeled, donor-derived, T-cells and third party MSCs in BMT recipients using multispectral cryo-imaging. Specific MSC homing sites were identified in the marginal zones in the spleen and the lymph nodes, where we believe MSC immunomodulation takes place. The number of MSCs found in spleen of the allo BMT recipients was about 200% more than that observed in the syngeneic group. To more carefully define the effects MSCs had on T cell activation and expansion, we developed novel T-cell proliferation assays including secondary lymphoid organ (SLO) enlargement and Carboxyfluoescein succinimidyl ester (CFSE) dilution. As anticipated, significant SLO volume enlargement and CFSE dilution was observed in allo but not syn BMT recipients due to rapid proliferation and expansion of labeled T-cells. MSC treatment markedly attenuated CFSE dilution and volume enlargement of SLO. These assays confirm evidence of potent, in vivo, immunomodulatory properties of MSC following allo BMT. Our innovative platform includes novel methods for tracking cells of interest as well as assessing therapeutic function of MSCs during GVHD induction. Our results support the use of MSCs treatment or prevention of GVHD and illuminate the wider adoption of MSCs as a standard medicinal cell therapy.
first_indexed 2024-04-09T22:57:01Z
format Article
id doaj.art-2a8ece5d6dbb4aeaa2bcf1b970a13aed
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T22:57:01Z
publishDate 2023-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-2a8ece5d6dbb4aeaa2bcf1b970a13aed2023-03-22T11:09:59ZengNature PortfolioScientific Reports2045-23222023-01-0113111310.1038/s41598-023-28478-3Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imagingPatiwet Wuttisarnwattana0Saada Eid1David L. Wilson2Kenneth R. Cooke3Optimization Theory and Applications for Engineering Systems Research Group, Department of Computer Engineering, Excellence Center in Infrastructure Technology and Transportation Engineering, Biomedical Engineering Institute, Chiang Mai UniversityDepartment of Pediatrics, Case Western Reserve UniversityDepartment of Biomedical Engineering, Case Western Reserve UniversityDepartment of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Johns Hopkins UniversityAbstract Insights regarding the biodistribution and homing of mesenchymal stromal cells (MSCs), as well as their interaction with alloreactive T-cells are critical for understanding how MSCs can regulate graft-versus-host disease (GVHD) following allogeneic (allo) bone marrow transplantation (BMT). We developed novel assays based on 3D, microscopic, cryo-imaging of whole-mouse-sized volumes to assess the therapeutic potential of human MSCs using an established mouse GVHD model. Following infusion, we quantitatively tracked fluorescently labeled, donor-derived, T-cells and third party MSCs in BMT recipients using multispectral cryo-imaging. Specific MSC homing sites were identified in the marginal zones in the spleen and the lymph nodes, where we believe MSC immunomodulation takes place. The number of MSCs found in spleen of the allo BMT recipients was about 200% more than that observed in the syngeneic group. To more carefully define the effects MSCs had on T cell activation and expansion, we developed novel T-cell proliferation assays including secondary lymphoid organ (SLO) enlargement and Carboxyfluoescein succinimidyl ester (CFSE) dilution. As anticipated, significant SLO volume enlargement and CFSE dilution was observed in allo but not syn BMT recipients due to rapid proliferation and expansion of labeled T-cells. MSC treatment markedly attenuated CFSE dilution and volume enlargement of SLO. These assays confirm evidence of potent, in vivo, immunomodulatory properties of MSC following allo BMT. Our innovative platform includes novel methods for tracking cells of interest as well as assessing therapeutic function of MSCs during GVHD induction. Our results support the use of MSCs treatment or prevention of GVHD and illuminate the wider adoption of MSCs as a standard medicinal cell therapy.https://doi.org/10.1038/s41598-023-28478-3
spellingShingle Patiwet Wuttisarnwattana
Saada Eid
David L. Wilson
Kenneth R. Cooke
Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
Scientific Reports
title Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
title_full Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
title_fullStr Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
title_full_unstemmed Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
title_short Assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft-versus-host disease using cryo-imaging
title_sort assessment of the therapeutic role of mesenchymal stromal cells in a mouse model of graft versus host disease using cryo imaging
url https://doi.org/10.1038/s41598-023-28478-3
work_keys_str_mv AT patiwetwuttisarnwattana assessmentofthetherapeuticroleofmesenchymalstromalcellsinamousemodelofgraftversushostdiseaseusingcryoimaging
AT saadaeid assessmentofthetherapeuticroleofmesenchymalstromalcellsinamousemodelofgraftversushostdiseaseusingcryoimaging
AT davidlwilson assessmentofthetherapeuticroleofmesenchymalstromalcellsinamousemodelofgraftversushostdiseaseusingcryoimaging
AT kennethrcooke assessmentofthetherapeuticroleofmesenchymalstromalcellsinamousemodelofgraftversushostdiseaseusingcryoimaging